Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Aave’s yield comparison tool brings quick deposits to Aave Pro

Aave’s yield comparison tool brings quick deposits to Aave Pro

CryptonomistCryptonomist2026/10/23 18:03

Aave has launched Earn, a feature that brings yield comparison and quick deposits together on Aave Pro. Introduced on October 23, 2026, the tool lets users compare assets by APY, choose a V4 market and deposit, with the aim of making the process easier to use.

How Aave’s yield comparison tool works

Earn allows users to compare yields across assets before choosing where to deposit. Aave’s announcement describes a process built around three actions: reviewing APYs, selecting a preferred market and depositing assets quickly.

The market-selection step focuses on V4 markets within Aave Pro. Users can choose among those markets as part of the deposit process, rather than using Earn only to view yield comparisons.

Its stated functionality centers on comparing available yields and making deposits, bringing those actions together within Aave Pro.

The launch aims to improve the user experience and streamline deposits on Aave Pro. Easier yield comparison is also intended to encourage greater engagement with the platform; that is a goal of the feature, not a reported adoption result.

Aave’s yield comparison feature arrives amid mixed conditions in the broader crypto market, with most altcoins trading sideways on October 23. The product launch adds a user-facing development against that backdrop.

The practical focus remains the deposit process: Earn supports comparison across different assets, selection among Aave Pro’s V4 markets and quick deposits into the chosen market.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

JPMorgan maintains "Neutral" rating on Johnson & Johnson (JNJ.US): Strong data from two anti-cancer drugs, but valuation premium limits upside potential

Johnson & Johnson’s new prostate cancer drug and head and neck cancer drug Ervantumab both released positive data at ESMO. JPMorgan stated that the pipeline shows differentiated potential but valuations are relatively high, maintaining a Neutral rating.

智通财经•2026/10/26 06:37

AI trading hype fades and product competition intensifies: SK Hynix (SKHY.US) leveraged ETF delisted from US stock market and liquidated just three months after launch

Two U.S. leveraged ETFs linked to SK Hynix (SKHY.US)—the Tradr 2X Long SK Hynix Daily ETF and the Tradr 2X Short SK Hynix Daily ETF—will be liquidated around November 12, approximately three months after their listing on July 28.

智通财经•2026/10/26 06:32
AI trading hype fades and product competition intensifies: SK Hynix (SKHY.US) leveraged ETF delisted from US stock market and liquidated just three months after launch

Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

华尔街见闻•2026/10/26 05:56
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.